Stay updated on Lonca Tesirine + Ibrutinib in Lymphoma Clinical Trial
Sign up to get notified when there's something new on the Lonca Tesirine + Ibrutinib in Lymphoma Clinical Trial page.

Latest updates to the Lonca Tesirine + Ibrutinib in Lymphoma Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedAdds a 2018 U.S. NIH Grant/Contract funding line and updates the page revision from v3.6.5 to v3.6.6, reflecting administrative record updates.SummaryDifference0.1%

- Check24 days agoNo Change Detected
- Check38 days agoChange DetectedThe page's revision label changed from v3.6.4 to v3.6.5, indicating the page has been updated to a newer revision.SummaryDifference0.0%

- Check53 days agoChange DetectedRevision: v3.6.4 has been added, replacing the previous Revision: v3.6.3. This indicates a page update that does not modify the study details or core content presented to users.SummaryDifference0.0%

- Check74 days agoChange DetectedA new page revision v3.6.3 was added, replacing the prior v3.6.2.SummaryDifference0.0%

- Check81 days agoChange DetectedRevision: v3.6.2 is now displayed, replacing the previous v3.6.0. This indicates a minor maintenance/version update to the page rather than a change to the study information.SummaryDifference0.0%

- Check95 days agoChange DetectedRecruitment status updated to indicate enrollment is closed, signaling that the study is not currently seeking participants. The page now reflects that participant enrollment has ended, informing visitors that no new participants can join at this time.SummaryDifference0.4%

Stay in the know with updates to Lonca Tesirine + Ibrutinib in Lymphoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Lonca Tesirine + Ibrutinib in Lymphoma Clinical Trial page.